Cases
Cases 61 - 70 of 178
Eisai Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01336
Plaintiff: Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant: Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court: Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. LUPIN LIMITED et al
as 3:2019cv07165
Plaintiff: JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant: LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 28 U.S.C. § 1338
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2019cv00347
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al
as 3:2018cv16708
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant: LUPIN LIMITED and LUPIN ATLANTIS HOLDINGS SA
Cause Of Action: 15 U.S.C. § 1126
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al We have downloadable decisions or orders for this case
as 1:2018cv01606
Defendant: Encube Ethicals Pvt. Ltd., Lupin Pharmaceuticals, Inc., FlatWing Pharmaceuticals, LLC and others
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al We have downloadable decisions or orders for this case
as 3:2018cv12663
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: LUPIN LIMITED and LUPIN ATLANTIS HOLDINGS SA
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDING SA et al
as 3:2018cv12662
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant: LUPIN ATLANTIS HOLDING SA and LUPIN LIMITED
Cause Of Action: 15 U.S.C. § 1126
H. Lundbeck A/S et al v. Lupin Limited et al
as 1:2018cv00777
Plaintiff: H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_claimant: Lupin Limited
Counter_defendant: H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals America, Inc. and others
Cause Of Action: 35 U.S.C. § 271
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 2:2018cv04225
Plaintiff: TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant: LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?